Scientific Advisory Board

Peter J. Barnes, FMedSci, F.R.S., Imperial College School of Medicine,

London, UK Pulmonary diseases

David Benditt, M.D., University of Minnesota Medical School, Minneapolis, MN

Cardiac electrophysiology, neurally-mediated syncope

Francesco DiVirgilio, M.D., University of Ferrara, Ferrara, Italy

P2 receptors in immunology

Daniel Flammang, M.D., Centre Hospitalier d'Angouleme, Angouleme, France

ATP in the management of patients with syncope

Jane Kinsel, Ph.D., M.B.A., Boston University, Boston, MA

Pharma industry, drug development

Donald A. McAfee, Ph.D., VP New Product Development, Cardiome Pharma Corp., Vancouver, B.C., Canada Biopharmaceutical industry, neurophysiology

Pasquale Patrizio, M.D., Yale University-Fertility Center, New Haven, CT

Andrology, male fertility

Riccardo Polosa, M.D., Ph.D., University of Catania, Catania, Italy.

Chronic obstructive pulmonary disorders

info@cordexpharma.com

Corporate